Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error for the study record, with a simple 403 header and navigation replacing the previous content. Many study-related sections and terms were removed, resulting in an error-state page.SummaryDifference18%

- Check36 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page or its metadata rather than a change to the study details. It does not alter the information presented about the trial.SummaryDifference0.1%

- Check57 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing v3.6.4. This is a minor software version update and does not change study content or page functionality.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision marker updated to v3.6.4 on the page footer, indicating a new deployment. The study content and data remain unchanged.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page footer shows Revision: v3.6.3, replacing v3.6.2, indicating a small maintenance update to the site.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a platform/template update that affects the page wrapper rather than study information.SummaryDifference0.1%

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.